Search

Search Constraints

You searched for: Author/Creator Owari, Takuya

Search Results

1. Amrubicin is effective against small cell carcinoma of the prostate as a second‐line chemotherapeutic agent: A case report. Issue 3 (7th March 2019)

3. Assessment of bladder function for stabilizing urinary volume overnight with recording of brain waves (ABSORB study). Issue 1 (25th September 2021)

4. Biochemical control of the combination of cyclooxygenase‐2 inhibitor and 125I‐brachytherapy for prostate cancer: Post hoc analysis of an open‐label controlled randomized trial. (26th June 2020)

5. Clinical benefit of early treatment with bone‐modifying agents for preventing skeletal‐related events in patients with genitourinary cancer with bone metastasis: A multi‐institutional retrospective study. (18th March 2019)

6. Comparison of disease‐specific quality of life in prostate cancer patients treated with low‐dose‐rate brachytherapy: A randomized controlled trial of silodosin versus naftopidil. (10th August 2021)

7. Diagnostic and prognostic role of urinary collagens in primary human bladder cancer. Issue 11 (15th September 2017)

8. Dual benefit of supplementary oral 5‐aminolevulinic acid to pelvic radiotherapy in a syngenic prostate cancer model. Issue 4 (18th November 2018)

9. Hexylaminolevulinate‐mediated fluorescent urine cytology with a novel automated detection technology for screening and surveillance of bladder cancer. (16th April 2021)

10. Impact of neoadjuvant androgen deprivation therapy on postimplant prostate D90 and prostate volume after low‐dose‐rate brachytherapy for localized prostate cancer. (11th November 2021)